Shanghai RAAS Blood Products Co., Ltd. (002252.SZ)
CNY 6.71
(0.3%)
CNY 6.71
(0.3%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 7.96 Billion CNY | 20.69% |
| 2022 | 6.56 Billion CNY | 53.16% |
| 2021 | 4.28 Billion CNY | 55.26% |
| 2020 | 2.76 Billion CNY | 6.84% |
| 2019 | 2.58 Billion CNY | 43.27% |
| 2018 | 1.8 Billion CNY | -6.41% |
| 2017 | 1.92 Billion CNY | -17.13% |
| 2016 | 2.32 Billion CNY | 15.54% |
| 2015 | 2.01 Billion CNY | 52.55% |
| 2014 | 1.31 Billion CNY | 165.88% |
| 2013 | 496.35 Million CNY | -25.1% |
| 2012 | 662.67 Million CNY | 16.79% |
| 2011 | 567.38 Million CNY | 17.38% |
| 2010 | 483.35 Million CNY | 24.73% |
| 2009 | 387.51 Million CNY | 25.06% |
| 2008 | 309.86 Million CNY | -0.04% |
| 2007 | 309.97 Million CNY | 11.23% |
| 2006 | 278.68 Million CNY | -8.08% |
| 2005 | 303.19 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 2.04 Billion CNY | 1.22% |
| 2024 Q3 | 2.06 Billion CNY | -5.34% |
| 2024 Q2 | 2.17 Billion CNY | 6.58% |
| 2023 Q4 | 2.01 Billion CNY | -0.76% |
| 2023 Q3 | 2.03 Billion CNY | 10.73% |
| 2023 Q2 | 1.83 Billion CNY | -10.93% |
| 2023 FY | 7.92 Billion CNY | 20.69% |
| 2023 Q1 | 2.06 Billion CNY | 27.69% |
| 2022 Q2 | 1.6 Billion CNY | -4.6% |
| 2022 FY | 6.56 Billion CNY | 53.16% |
| 2022 Q4 | 1.61 Billion CNY | -2.56% |
| 2022 Q1 | 1.68 Billion CNY | 35.8% |
| 2022 Q3 | 1.65 Billion CNY | 3.11% |
| 2021 FY | 4.28 Billion CNY | 55.26% |
| 2021 Q2 | 901.51 Million CNY | 5.54% |
| 2021 Q1 | 854.2 Million CNY | 18.05% |
| 2021 Q4 | 1.24 Billion CNY | -3.84% |
| 2021 Q3 | 1.29 Billion CNY | 43.18% |
| 2020 FY | 2.76 Billion CNY | 6.84% |
| 2020 Q4 | 723.61 Million CNY | -0.7% |
| 2020 Q1 | 731.87 Million CNY | 9.37% |
| 2020 Q2 | 577.43 Million CNY | -21.1% |
| 2020 Q3 | 728.75 Million CNY | 26.21% |
| 2019 Q1 | 584.66 Million CNY | 47.94% |
| 2019 FY | 2.58 Billion CNY | 43.27% |
| 2019 Q4 | 669.2 Million CNY | 8.17% |
| 2019 Q3 | 618.65 Million CNY | -13.17% |
| 2019 Q2 | 712.46 Million CNY | 21.86% |
| 2018 Q1 | 317.49 Million CNY | -31.0% |
| 2018 Q3 | 448.27 Million CNY | -30.31% |
| 2018 Q2 | 643.26 Million CNY | 102.61% |
| 2018 Q4 | 395.19 Million CNY | -11.84% |
| 2018 FY | 1.8 Billion CNY | -6.41% |
| 2017 Q4 | 460.13 Million CNY | -23.34% |
| 2017 Q2 | 465.6 Million CNY | 15.89% |
| 2017 Q1 | 401.76 Million CNY | -43.37% |
| 2017 FY | 1.92 Billion CNY | -17.13% |
| 2017 Q3 | 600.25 Million CNY | 28.92% |
| 2016 Q2 | 551.74 Million CNY | 13.32% |
| 2016 Q3 | 578.14 Million CNY | 4.78% |
| 2016 Q4 | 709.48 Million CNY | 22.72% |
| 2016 FY | 2.32 Billion CNY | 15.54% |
| 2016 Q1 | 486.87 Million CNY | -6.61% |
| 2015 Q3 | 675.37 Million CNY | 46.69% |
| 2015 Q4 | 521.35 Million CNY | -22.8% |
| 2015 Q2 | 460.41 Million CNY | 29.27% |
| 2015 Q1 | 356.17 Million CNY | -27.84% |
| 2015 FY | 2.01 Billion CNY | 52.55% |
| 2014 Q1 | 254.21 Million CNY | 661.77% |
| 2014 Q3 | 284.03 Million CNY | -1.34% |
| 2014 FY | 1.31 Billion CNY | 165.88% |
| 2014 Q4 | 493.57 Million CNY | 73.77% |
| 2014 Q2 | 287.9 Million CNY | 13.25% |
| 2013 Q4 | 33.37 Million CNY | -80.19% |
| 2013 FY | 496.35 Million CNY | -25.1% |
| 2013 Q3 | 168.47 Million CNY | -16.1% |
| 2013 Q2 | 200.81 Million CNY | 114.31% |
| 2013 Q1 | 93.69 Million CNY | -61.34% |
| 2012 Q1 | 71.54 Million CNY | -61.47% |
| 2012 Q2 | 165.94 Million CNY | 131.95% |
| 2012 Q3 | 182.83 Million CNY | 10.18% |
| 2012 Q4 | 242.35 Million CNY | 32.55% |
| 2012 FY | 662.67 Million CNY | 16.79% |
| 2011 Q3 | 155.25 Million CNY | 2.97% |
| 2011 Q2 | 150.77 Million CNY | 99.27% |
| 2011 Q1 | 75.66 Million CNY | -50.38% |
| 2011 FY | 567.38 Million CNY | 17.38% |
| 2011 Q4 | 185.68 Million CNY | 19.6% |
| 2010 Q3 | 141.6 Million CNY | 19.58% |
| 2010 FY | 483.35 Million CNY | 24.73% |
| 2010 Q2 | 118.41 Million CNY | 67.12% |
| 2010 Q1 | 70.85 Million CNY | -50.12% |
| 2010 Q4 | 152.48 Million CNY | 7.69% |
| 2009 Q1 | 68.58 Million CNY | -6.55% |
| 2009 Q3 | 82.84 Million CNY | -11.91% |
| 2009 Q4 | 142.04 Million CNY | 71.46% |
| 2009 FY | 387.51 Million CNY | 25.06% |
| 2009 Q2 | 94.04 Million CNY | 37.13% |
| 2008 FY | 309.86 Million CNY | -0.04% |
| 2008 Q4 | 73.38 Million CNY | 22.52% |
| 2008 Q3 | 59.89 Million CNY | -32.66% |
| 2008 Q2 | 88.94 Million CNY | 1.5% |
| 2008 Q1 | 87.63 Million CNY | 1.02% |
| 2007 FY | 309.97 Million CNY | 11.23% |
| 2007 Q1 | 101.45 Million CNY | 0.0% |
| 2007 Q3 | 55.51 Million CNY | -16.22% |
| 2007 Q4 | 86.74 Million CNY | 56.25% |
| 2007 Q2 | 66.26 Million CNY | -34.68% |
| 2006 FY | 278.68 Million CNY | -8.08% |
| 2005 FY | 303.19 Million CNY | 0.0% |